Professional Documents
Culture Documents
IFRS Illustrative Financial Statements 2012
IFRS Illustrative Financial Statements 2012
IFRS Illustrative Financial Statements 2012
1st – Identify the acquirer and the acquisition date and determine the existence of CONTROL between the
acquirer (PARENT) and acquiree.
Prepared by iPass Training and Consultancy, Addis Ababa, Ethiopia, 2016 Page 1
Intercompany Receivables will be Eliminated (on the consolidated SOFP)
Recognize and record any goodwill arising on acquisition (Working #3)
o Combine (add) all of the Liabilities of the Parent with all of the Liabilities of the Sub
Deferred tax liability might be recognized (Working #2)
Intercompany Payables will be Eliminated ( On the Consolidated SOFP)
o Take 100% of the equity of the parent only
Post-acquisition profit/loss of the Sub that belongs to the parent will be recognized in group Retained earning
(Working #5)
Post-acquisition OCI of the sub that belongs to the parent will be recognized in the group OCI (Working #6)
o Eliminate the Investment account in the parent’s record along with the equity of the sub
- For Consolidated Statement of Comprehensive Income
o Combine (add) all of the revenues of the parent with all of the revenues of the Sub
Deduct (eliminate) intercompany sales made between the parent and the sub
Deduct (eliminate) intercompany income
N.B- Time apportion the revenue of the sub, if the sub acquisition is made mid-year
o Combine (add) all of the expenses of the parent with all of the expenses of the Sub
Add Provision for Unrealized Profit (PUP) on Cost of Sales
Adjust for additional expenses resulting from fair value exercise made up on acquisition
Deduct (eliminate) intercompany expense
Prepared by iPass Training and Consultancy, Addis Ababa, Ethiopia, 2016 Page 2
Determine and record any impairment on goodwill
N.B- Time Apportion the costs and expenses of the sub, if the sub acquisition occurred mid-year
N.B- Transaction cost of acquiring a subsidiary should be excluded for cost of investment and treated as follows
Cost of issuing shares in a share for share exchange for acquisition of a sub
Dr. Share Premium
Cr. Cash (Payable)
Other costs of acquisition such as legal, due diligence and professional fees
Dr. Expense
Cr. Cash (Payable)
o Apportion the profit and total comprehensive income as attributable to:
Non-Controlling Interest
Controlling Interest
3rd- If control doesn’t exist but either joint control or significant influence is proved, use Equity
accounting (IAS 28 and IFRS 11).
o Record the investment made
Dr. Investment in Associate
Cr. Cash (payable)
Prepared by iPass Training and Consultancy, Addis Ababa, Ethiopia, 2016 Page 3
o Record the parent’s portion of associate’s profit/loss after acquisition
Dr. Investment in Associate
Cr. Investment Income
o Deduct dividend paid by the associate to the parent from investment income
Dr. Cash
Cr. Investment in Associate
o Recognize any impairment of the associate
Dr. Investment Income
Cr. Investment in Associate
4th- If there is no control, no joint control or no significant influence, then apply IFRS 9 as follows;
o Record the investment made (same journal entry for FVTPL and FVTOCI)
Dr. Financial Asset
Cr. Cash (Payable)
o Record Transaction cost incurred to acquire the financial instrument
If the instrument is designated as FVTPL- Transaction cost is expensed
Dr. Expense
Cr. Cash (payable)
Prepared by iPass Training and Consultancy, Addis Ababa, Ethiopia, 2016 Page 4
If the instrument is designated as FVTOCI- Transaction cost is capitalized
Dr. Financial Asset
Cr. Cash (payable)
o Record dividend received as an investment income ( Same journal entry for FVTPL and FVTOCI)
Dr. Cash
Cr. Investment Income
o Measure the fair value at the end of every year and record the fair value movement
If the instrument is designated as FVTPL
Dr. Financial Asset
Gain on Financial Asset (to be reported in PL)
If the instrument is designated as FVTOCI
Dr. Financial Asset
Gain on Financial Asset (to be reported in OCI)
Prepared by iPass Training and Consultancy, Addis Ababa, Ethiopia, 2016 Page 5